U.S. Markets closed

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
30.94-1.11 (-3.46%)
At close: 4:00PM EDT
30.94 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close32.05
Bid30.37 x 900
Ask31.01 x 900
Day's Range30.86 - 32.47
52 Week Range25.72 - 64.37
Avg. Volume839,020
Market Cap2.858B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateAug 25, 2021 - Aug 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est54.33
  • Motley Fool

    Why Relay Therapeutics Is Up 30% This Week

    What happened Shares of Relay Therapeutics (NASDAQ: RLAY), a clinical-stage biopharmaceutical company, have risen about 30% since the stock's closing price last Friday. Investors are highly encouraged by interim clinical trial data that suggest the company's new approach to drug development can produce a new blockbuster cancer treatment.

  • GlobeNewswire

    Relay Therapeutics Announces Pricing of Public Offering of Common Stock

    CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced today the pricing of an underwritten public offering of 13,207,547 shares of its common stock at a public offering price of $26.50 per share. Relay Therapeutics also granted the underwriters a 30-day option to purchase up to an additional 1,9

  • Benzinga

    5 Stocks To Watch For October 12, 2021

    Some of the stocks that may grab investor focus today are: Wall Street expects Fastenal Company (NASDAQ: FAST) to report quarterly earnings at $0.42 per share on revenue of $1.54 billion before the opening bell. Fastenal shares fell 2% to $51.20 in after-hours trading. Arch Capital Group (NASDAQ: ACGL) raised its buyback plan to $1.5 billion. The company also said it sees Q3 pre-tax net catastrophe losses of $330 million to $345 million. Arch Capital shares gained 1.1% to $40.59 in the after-hou